Bio-Rad Laboratories Inc.

NYSE: BIO · Real-Time Price · USD
287.52
0.31 (0.11%)
At close: Aug 15, 2025, 1:11 PM

Bio-Rad Laboratories Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.57B 2.67B 2.8B 2.92B
Cost of Revenue
1.19B 1.24B 1.23B 1.28B
Gross Profit
1.38B 1.43B 1.57B 1.64B
Operating Income
269M 337.8M 482.62M 500.34M
Interest Income
82M 100.9M 58M 18.9M
Pretax Income
-2.34B -850.1M -4.7B 5.45B
Net Income
-1.84B -637.32M -3.63B 4.25B
Selling & General & Admin
814M 841.7M 827.83M 877.12M
Research & Development
295.9M 247.43M 256.89M 260.64M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
1.11B 1.09B 1.08B 1.14B
Interest Expense
48.9M 49.44M 38.11M 1.55M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
2.3B 2.33B 2.32B 2.42B
Income Tax Expense
-498.3M -212.78M -1.08B 1.19B
Shares Outstanding (Basic)
28.21M 29.21M 29.79M 29.83M
Shares Outstanding (Diluted)
28.21M 29.21M 29.79M 30.21M
EPS (Basic)
-65.36 -21.82 -121.79 142.61
EPS (Diluted)
-65.36 -21.82 -121.79 140.83
EBITDA
-2.14B -654.8M -4.49B 5.59B
EBIT
-2.29B -800.66M -4.67B 5.45B
Depreciation & Amortization
151.6M 145.9M 177.2M 137.6M